Does NNI want the field to fail?

Quote

anonymous

Guest
What action has NNI America done for the field that has set us up to win? obesity? Endo? DCS?
All failures..
The new emergency panic kit is NNI response to Lilly… hit the button a rep will appear with coupons. We don’t actually have samples..
LAYOFF OTW
 




anonymous said:
What action has NNI America done for the field that has set us up to win? obesity? Endo? DCS?
All failures..
The new emergency panic kit is NNI response to Lilly… hit the button a rep will appear with coupons. We don’t actually have samples..
LAYOFF OTW
Click to expand...
Novo is inept. Happy thanksgiving everyone. Start looking now.
 




Correct… how was training on Mounjaro? Do you feel prepared ? $25 cash coupon good for all vs. begging for samples from NNI rep with inferior drug… oh wait doc hit this red button and I am OTW with a coupon that is no longer relevant
 




Of course that is what their plan is, our IC falls short but somehow they still their anchor budget and they get the big bonus payouts and all of this smoke and mirrors is just another way to justify another round of lay-offs. That is the NNI Way.

They have known for some time there is a supply issue with Ozempic yet they keep hiding behind the curtain and tell us is sporadic and only is certain parts of the country. They've known for months and months. And to make up for no samples, we've been pushed to using vouchers, now some area managers (TJ - which is a WHOLE topic of WTF in itself) are running reports and calling out reps with high voucher redemption rates.

But let's stick our heads in the sand even further and make sure you are making 2 pharmacy calls a day??

How can leadership be so out of touch?

Anyone care to guess what sort of percentage increase goals will be for Q3 (no samples, supply shortage at pharmacy, and mounjaro)?
 
















anonymous said:
It was all fun and games watching endless mistakes by leadership. now the mkt has changed, jobs will pay the price
Field to layoff soon.
Click to expand...

How long can we sustain this giant salesforce with this one molecule? That is the one thing that causes worry for me. 2 teams of educators, 2 different managers, still many pods of 3 reps per territory on the diabetes side, e reps (who often times have lower volumes than the dcs reps), all promoting the same molecule. We have up to 6 different Novo reps ( + 2 different managers) coming into certain offices talking about sema.
 








anonymous said:
How long can we sustain this giant salesforce with this one molecule? That is the one thing that causes worry for me. 2 teams of educators, 2 different managers, still many pods of 3 reps per territory on the diabetes side, e reps (who often times have lower volumes than the dcs reps), all promoting the same molecule. We have up to 6 different Novo reps ( + 2 different managers) coming into certain offices talking about sema.
Click to expand...
Why has it taken you or anybody else this long to realize this? Even after the layoffs year and a half ago we were still too big for one molecule. Now the manufacturing issues and the ass whooping Lilly is about to give us? Novo is too dumb to get out of its own way. The stock may be worth $100+ but I wouldn’t trust this leadership team with a penny stock company. The end of the year is not looking positive. Best of luck all.
 




Anyone that thinks an increased guidance is a good sign is in for a rude awakening. investors will flip if we lowered our guidance after increasing it this year. Novo execs sent a clear message internally: the profit train must go up and up! including if that means axing HO and field employees to keep that train moving strong. They can disappoint employees, payers. but can't afford having disgruntled investors.
We all know there's too many people doing the same job around here.
 








Did no one take notice when they updated Veeva last year? Where the DBMs can access both Diabetes and Obesity? There was reference to making that change for future use. As soon as I heard that I suspect all will merge into one team. One DBM for DCS, OCS, EDCS and DE. When I launched Saxenda we were in the same district as our DCS counterparts.
 




The grind is… field is about to get right sized not bc of performance but because NNI can’t supply products to patients. Zero leadership from NJ or Denmark on this issue. Obesity already got a $50k gift because NNI can’t forecast and plan ahead.
 




anonymous said:
How long can we sustain this giant salesforce with this one molecule? That is the one thing that causes worry for me. 2 teams of educators, 2 different managers, still many pods of 3 reps per territory on the diabetes side, e reps (who often times have lower volumes than the dcs reps), all promoting the same molecule. We have up to 6 different Novo reps ( + 2 different managers) coming into certain offices talking about sema.
Click to expand...

actually in that one office, they might see a possible 4 different managers, for up to 10 NNI people in one office. For one product.

3 diabetes reps, 1 ocs, 1 DE, 1 OE, 1 DE manager, 1 OE Manager, 1 OCS Manager, 1 DBM.

Did anyone catch that one Q&A on yesterday's call about the 'pilot program', I think that answers some questions...
 




anonymous said:
actually in that one office, they might see a possible 4 different managers, for up to 10 NNI people in one office. For one product.

3 diabetes reps, 1 ocs, 1 DE, 1 OE, 1 DE manager, 1 OE Manager, 1 OCS Manager, 1 DBM.

Did anyone catch that one Q&A on yesterday's call about the 'pilot program', I think that answers some questions...
Click to expand...

Missed this. What they say?
 




I did, during the q and a segment someone asked what the new 'direction' for the DEs really means under 'cardio-metabolic' and if they might be combined with the OEs. It was stated that they are looking at this and already started a pilot where there will only be one educator for diab and ob.
 












anonymous said:
actually in that one office, they might see a possible 4 different managers, for up to 10 NNI people in one office. For one product.

3 diabetes reps, 1 ocs, 1 DE, 1 OE, 1 DE manager, 1 OE Manager, 1 OCS Manager, 1 DBM.

Did anyone catch that one Q&A on yesterday's call about the 'pilot program', I think that answers some questions...
Click to expand...

Think about the salary expenditure on just those 4 managers alone. 1 manager could easily handle the dcs team of 6-10 ( depending on size of district), 1 edcs, 1 ocs and the one educator for each district. And better yet, let the DCS reps absorb the endo offices. Primary care is writing more of our product, at least in our region.
 




Top Bottom
Back
Quote